INS and type 1 diabetes mellitus: For participants with T1D, the main refusal reasons were patients had switched from continuous subcutaneous insulin infusion to multiple daily injection therapy (n = 6); were no longer using a CGM device (n = 7); could not be reached by phone (n = 28); and were no longer interested in the research topic (n = 12).